Editorial
A missed opportunity for urban health
Trauma: a neglected US public health emergency
Ageing in China: a ticking bomb
Comment
Treatment for severe eosinophilic asthma—consistent effect of anti-interleukin-5 antibodies?
Should blood pressure reduction be aggressive in patients with hypertension and coronary artery disease?
Maternal health: time for a radical reappraisal
Implementation and aspiration gaps: whose view counts?
Research in planetary health: a call for abstracts
Articles
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study